Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117918422 | 11791842 | 2 | F | 201505 | 20160813 | 20151201 | 20160823 | EXP | US-BAYER-2014-064680 | BAYER | 26.00 | YR | A | F | Y | 68.27000 | KG | 20160823 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117918422 | 11791842 | 1 | PS | ADEMPAS | RIOCIGUAT | 1 | UNK | 204819 | |||||||||||
| 117918422 | 11791842 | 2 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 1.5 MG, TID | BXGGF91A | 204819 | 1.5 | MG | TID | ||||||
| 117918422 | 11791842 | 3 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 1 MG, TID | BXGGF81A | 204819 | 1 | MG | TID | ||||||
| 117918422 | 11791842 | 4 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 1 MG, TID | BXH0L11 | 204819 | 1 | MG | TID | ||||||
| 117918422 | 11791842 | 5 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 1 MG, TID (LAST SHIPPED 03-AUG-2015) | BXH0L11 | 204819 | 1 | MG | TID | ||||||
| 117918422 | 11791842 | 6 | SS | ADEMPAS | RIOCIGUAT | 1 | 1 MG, TID (LAST SHIPPED ON 22-JUL-2016) | BXH94J1 | 204819 | 1 | MG | TID | |||||||
| 117918422 | 11791842 | 7 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 0 | ||||||||||||
| 117918422 | 11791842 | 8 | C | OPSUMIT | MACITENTAN | 1 | 0 | ||||||||||||
| 117918422 | 11791842 | 9 | C | COUMADIN | WARFARIN SODIUM | 1 | 0 | ||||||||||||
| 117918422 | 11791842 | 10 | C | FLOLAN [EPOPROSTENOL SODIUM] | 2 | 0 | |||||||||||||
| 117918422 | 11791842 | 11 | C | IUD NOS | COPPER OR LEVONORGESTREL | 1 | 0 | ||||||||||||
| 117918422 | 11791842 | 12 | C | REMODULIN | TREPROSTINIL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117918422 | 11791842 | 1 | Pulmonary arterial hypertension |
| 117918422 | 11791842 | 2 | Pulmonary arterial hypertension |
| 117918422 | 11791842 | 3 | Pulmonary arterial hypertension |
| 117918422 | 11791842 | 4 | Pulmonary arterial hypertension |
| 117918422 | 11791842 | 5 | Pulmonary arterial hypertension |
| 117918422 | 11791842 | 6 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117918422 | 11791842 | OT |
| 117918422 | 11791842 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117918422 | 11791842 | Abdominal discomfort | |
| 117918422 | 11791842 | Catheter site infection | |
| 117918422 | 11791842 | Device connection issue | |
| 117918422 | 11791842 | Device leakage | |
| 117918422 | 11791842 | Diarrhoea | |
| 117918422 | 11791842 | Dizziness | |
| 117918422 | 11791842 | Drug dose omission | |
| 117918422 | 11791842 | Headache | |
| 117918422 | 11791842 | Hospitalisation | |
| 117918422 | 11791842 | Inappropriate schedule of drug administration | |
| 117918422 | 11791842 | Nasal congestion | |
| 117918422 | 11791842 | Nasopharyngitis | |
| 117918422 | 11791842 | Nausea | |
| 117918422 | 11791842 | Palpitations | |
| 117918422 | 11791842 | Tooth disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117918422 | 11791842 | 1 | 20140210 | 0 | ||
| 117918422 | 11791842 | 2 | 20140213 | 0 |